<code id='761370A582'></code><style id='761370A582'></style>
    • <acronym id='761370A582'></acronym>
      <center id='761370A582'><center id='761370A582'><tfoot id='761370A582'></tfoot></center><abbr id='761370A582'><dir id='761370A582'><tfoot id='761370A582'></tfoot><noframes id='761370A582'>

    • <optgroup id='761370A582'><strike id='761370A582'><sup id='761370A582'></sup></strike><code id='761370A582'></code></optgroup>
        1. <b id='761370A582'><label id='761370A582'><select id='761370A582'><dt id='761370A582'><span id='761370A582'></span></dt></select></label></b><u id='761370A582'></u>
          <i id='761370A582'><strike id='761370A582'><tt id='761370A582'><pre id='761370A582'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:66675
          The logo of Department of Justice on a podium — coverage from STAT
          BRENDAN SMIALOWSKI/AFP via Getty Images

          Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling.

          CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissions, and inpatient dialysis at our hospitals.”

          advertisement

          The DOJ initiates these investigations into health care companies when it believes there could be a False Claims Act case, but has not initiated or joined any lawsuits yet.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Eli Lilly’s chief scientist on obesity drugs, gene editing, and more
          Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

          DanSkovronsky,EliLilly'schiefscientificofficer,atthe2023STATSummit.STATPHILADELPHIA—Inasense,theannu

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          FDA cancer chief on how to get things done: ‘Don’t tell anybody'

          AdobeWASHINGTON—TheFoodandDrugAdministration’stopcancerdrugregulatordoesn’talwaysaskforpermissionbef